Global GLP-1 Injection Pen 麻豆原创 Research Report 2024

Publication ID:

PB508245050

Publication Date:

August 23, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

GLP-1 (glucagon-like peptide-1) injection pens are medical devices used to administer medications that mimic the action of the naturally occurring hormone GLP-1.
The global GLP-1 Injection Pen market was valued at US$ 452 million in 2023 and is anticipated to reach US$ 630 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
North American market for GLP-1 Injection Pen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GLP-1 Injection Pen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of GLP-1 Injection Pen include Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Tonghua Dongbao Pharmaceutical, Owen Mumford, Gan&Lee Pharmaceuticals and Jiangsu Delfu medical devices, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GLP-1 Injection Pen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Injection Pen.
Report Scope
The GLP-1 Injection Pen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GLP-1 Injection Pen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 Injection Pen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Tonghua Dongbao Pharmaceutical
Owen Mumford
Gan&Lee Pharmaceuticals
Jiangsu Delfu medical devices
Hanerxi Medical
Segment by Type
Electronic Smart Injection Pen
Mechanical Injection Pen
Segment by Application
Diabetes
Obesity
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP-1 Injection Pen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP-1 Injection Pen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 GLP-1 Injection Pen 麻豆原创 Overview
1.1 Product Overview and Scope of GLP-1 Injection Pen
1.2 GLP-1 Injection Pen Segment by Type
1.2.1 Global GLP-1 Injection Pen 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Electronic Smart Injection Pen
1.2.3 Mechanical Injection Pen
1.3 GLP-1 Injection Pen Segment by Application
1.3.1 Global GLP-1 Injection Pen 麻豆原创 Value by Application: (2024-2030)
1.3.2 Diabetes
1.3.3 Obesity
1.4 Global GLP-1 Injection Pen 麻豆原创 Size Estimates and Forecasts
1.4.1 Global GLP-1 Injection Pen Revenue 2019-2030
1.4.2 Global GLP-1 Injection Pen Sales 2019-2030
1.4.3 Global GLP-1 Injection Pen 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 GLP-1 Injection Pen 麻豆原创 Competition by Manufacturers
2.1 Global GLP-1 Injection Pen Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global GLP-1 Injection Pen Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global GLP-1 Injection Pen Average Price by Manufacturers (2019-2024)
2.4 Global GLP-1 Injection Pen Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1 Injection Pen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Injection Pen, Product Type & Application
2.7 GLP-1 Injection Pen 麻豆原创 Competitive Situation and Trends
2.7.1 GLP-1 Injection Pen 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest GLP-1 Injection Pen Players 麻豆原创 Share by Revenue
2.7.3 Global GLP-1 Injection Pen 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GLP-1 Injection Pen Retrospective 麻豆原创 Scenario by Region
3.1 Global GLP-1 Injection Pen 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global GLP-1 Injection Pen Global GLP-1 Injection Pen Sales by Region: 2019-2030
3.2.1 Global GLP-1 Injection Pen Sales by Region: 2019-2024
3.2.2 Global GLP-1 Injection Pen Sales by Region: 2025-2030
3.3 Global GLP-1 Injection Pen Global GLP-1 Injection Pen Revenue by Region: 2019-2030
3.3.1 Global GLP-1 Injection Pen Revenue by Region: 2019-2024
3.3.2 Global GLP-1 Injection Pen Revenue by Region: 2025-2030
3.4 North America GLP-1 Injection Pen 麻豆原创 Facts & Figures by Country
3.4.1 North America GLP-1 Injection Pen 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America GLP-1 Injection Pen Sales by Country (2019-2030)
3.4.3 North America GLP-1 Injection Pen Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Injection Pen 麻豆原创 Facts & Figures by Country
3.5.1 Europe GLP-1 Injection Pen 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe GLP-1 Injection Pen Sales by Country (2019-2030)
3.5.3 Europe GLP-1 Injection Pen Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Injection Pen 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific GLP-1 Injection Pen 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific GLP-1 Injection Pen Sales by Country (2019-2030)
3.6.3 Asia Pacific GLP-1 Injection Pen Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Injection Pen 麻豆原创 Facts & Figures by Country
3.7.1 Latin America GLP-1 Injection Pen 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America GLP-1 Injection Pen Sales by Country (2019-2030)
3.7.3 Latin America GLP-1 Injection Pen Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GLP-1 Injection Pen 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Injection Pen 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa GLP-1 Injection Pen Sales by Country (2019-2030)
3.8.3 Middle East and Africa GLP-1 Injection Pen Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Injection Pen Sales by Type (2019-2030)
4.1.1 Global GLP-1 Injection Pen Sales by Type (2019-2024)
4.1.2 Global GLP-1 Injection Pen Sales by Type (2025-2030)
4.1.3 Global GLP-1 Injection Pen Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global GLP-1 Injection Pen Revenue by Type (2019-2030)
4.2.1 Global GLP-1 Injection Pen Revenue by Type (2019-2024)
4.2.2 Global GLP-1 Injection Pen Revenue by Type (2025-2030)
4.2.3 Global GLP-1 Injection Pen Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global GLP-1 Injection Pen Price by Type (2019-2030)
5 Segment by Application
5.1 Global GLP-1 Injection Pen Sales by Application (2019-2030)
5.1.1 Global GLP-1 Injection Pen Sales by Application (2019-2024)
5.1.2 Global GLP-1 Injection Pen Sales by Application (2025-2030)
5.1.3 Global GLP-1 Injection Pen Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global GLP-1 Injection Pen Revenue by Application (2019-2030)
5.2.1 Global GLP-1 Injection Pen Revenue by Application (2019-2024)
5.2.2 Global GLP-1 Injection Pen Revenue by Application (2025-2030)
5.2.3 Global GLP-1 Injection Pen Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global GLP-1 Injection Pen Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk GLP-1 Injection Pen Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly GLP-1 Injection Pen Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi GLP-1 Injection Pen Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD GLP-1 Injection Pen Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Ypsomed Holding
6.5.1 Ypsomed Holding Corporation Information
6.5.2 Ypsomed Holding Description and Business Overview
6.5.3 Ypsomed Holding GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ypsomed Holding GLP-1 Injection Pen Product Portfolio
6.5.5 Ypsomed Holding Recent Developments/Updates
6.6 Tonghua Dongbao Pharmaceutical
6.6.1 Tonghua Dongbao Pharmaceutical Corporation Information
6.6.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.6.3 Tonghua Dongbao Pharmaceutical GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Tonghua Dongbao Pharmaceutical GLP-1 Injection Pen Product Portfolio
6.6.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
6.7 Owen Mumford
6.6.1 Owen Mumford Corporation Information
6.6.2 Owen Mumford Description and Business Overview
6.6.3 Owen Mumford GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Owen Mumford GLP-1 Injection Pen Product Portfolio
6.7.5 Owen Mumford Recent Developments/Updates
6.8 Gan&Lee Pharmaceuticals
6.8.1 Gan&Lee Pharmaceuticals Corporation Information
6.8.2 Gan&Lee Pharmaceuticals Description and Business Overview
6.8.3 Gan&Lee Pharmaceuticals GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Gan&Lee Pharmaceuticals GLP-1 Injection Pen Product Portfolio
6.8.5 Gan&Lee Pharmaceuticals Recent Developments/Updates
6.9 Jiangsu Delfu medical devices
6.9.1 Jiangsu Delfu medical devices Corporation Information
6.9.2 Jiangsu Delfu medical devices Description and Business Overview
6.9.3 Jiangsu Delfu medical devices GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu Delfu medical devices GLP-1 Injection Pen Product Portfolio
6.9.5 Jiangsu Delfu medical devices Recent Developments/Updates
6.10 Hanerxi Medical
6.10.1 Hanerxi Medical Corporation Information
6.10.2 Hanerxi Medical Description and Business Overview
6.10.3 Hanerxi Medical GLP-1 Injection Pen Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hanerxi Medical GLP-1 Injection Pen Product Portfolio
6.10.5 Hanerxi Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Injection Pen Industry Chain Analysis
7.2 GLP-1 Injection Pen Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Injection Pen Production Mode & Process
7.4 GLP-1 Injection Pen Sales and 麻豆原创ing
7.4.1 GLP-1 Injection Pen Sales Channels
7.4.2 GLP-1 Injection Pen Distributors
7.5 GLP-1 Injection Pen Customers
8 GLP-1 Injection Pen 麻豆原创 Dynamics
8.1 GLP-1 Injection Pen Industry Trends
8.2 GLP-1 Injection Pen 麻豆原创 Drivers
8.3 GLP-1 Injection Pen 麻豆原创 Challenges
8.4 GLP-1 Injection Pen 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Tonghua Dongbao Pharmaceutical
Owen Mumford
Gan&Lee Pharmaceuticals
Jiangsu Delfu medical devices
Hanerxi Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.